Skip to main content
. Author manuscript; available in PMC: 2010 May 15.
Published in final edited form as: Cell. 2009 May 15;137(4):635–646. doi: 10.1016/j.cell.2009.03.016

Figure 3.

Figure 3

Metformin stimulates CBP phosphorylation through aPKCι/λ. (A) Metformin, AICAR, insulin and (B) AMPK overexpression stimulate CBP phosphorylation. (C) PI3K inhibitor LY294002 fails to inhibit CBP phosphorylation. CBP phosphorylation is blocked by RNAi or adenoviral shRNA-mediated knockdown aPKCι/λ in hepatocyte cells (D) or in liver (E). (F) Metformin treatment (5 h) in hepatocyte cells stimulates hepatic CBP phosphorylation in a concentration-dependent manner.